Edition:
India

Sun Pharmaceutical Industries Says USFDA Issued Form 483 With 11 Observations Post Inspection at Dadra Facility


Friday, 26 Apr 2019 

April 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::US FDA CONDUCTED AN INSPECTION OF CO.'S DADRA FACILITY FROM MARCH 22, 2019 TO MARCH 29.SUN PHARMACEUTICAL INDUSTRIES- POST INSPECTION, USFDA ISSUED A FORM 483, WITH 11 OBSERVATIONS.